| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 1059-1061, Copyright © 1995 by Endocrine Society
ARTICLES |
PJ Snyder
Division of Endocrinology, Metabolism and Diabetes, University of Pennsylvania School of Medicine, Philadelphia 19104-6149, USA.
Our experience with gonadotroph adenomas during the last 20 years has taught us how to recognize them by their size, neurologic symptoms, and inefficient and incomplete secretion of intact gonadotropins and their subunits. Treatment now is primarily by transsphenoidal surgery and secondarily by radiation. Future development of a pharmacologic treatment will likely await more detailed knowledge of their pathogenesis.
This article has been cited by other articles:
![]() |
T. Maruyama, H. Masuda, H. Uchida, T. Nagashima, and Y. Yoshimura Follicle Stimulating Hormone-Secreting Pituitary Microadenoma With Fluctuating Levels of Ovarian Hyperstimulation Obstet. Gynecol., May 1, 2005; 105(5): 1215 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Christin-Maitre, C. Rongières-Bertrand, M.-L. Kottler, N. Lahlou, R. Frydman, P. Touraine, and P. Bouchard A Spontaneous and Severe Hyperstimulation of the Ovaries Revealing a Gonadotroph Adenoma J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3450 - 3453. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |